Bicycle Therapeutics director Charles Swanton resigns from board, committees
BCYC•Director resignation
- Bicycle Therapeutics: Charles Swanton resigned as a Class II director, effective immediately on Aug. 18, 2026.
- Exit also covered his board committee roles and membership on the company’s Clinical Advisory Board.
- Resignation cited personal reasons.
- No disagreement with the company’s operations, policies, or practices was reported.
